(Q36692712)

15 August 2017

1 reference

title

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine (English)

1 reference

15 August 2017

1 reference

Paul M Szumita

1

1 reference

15 August 2017

Steven A Baroletti

series ordinal

2

1 reference

15 August 2017

Kevin E Anger

series ordinal

3

1 reference

15 August 2017

Michael E Wechsler

series ordinal

4

1 reference

15 August 2017

publication date

1 January 2007

1 reference

American Journal of Health-System Pharmacy

15 August 2017

published in

1 reference

15 August 2017

volume

64

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

37-44

1 reference

Patients requiring sedation.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Sedation in the intensive care unit: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

New agents for sedation in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol: a review of its use in intensive care sedation of adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol: an immunomodulating agent

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol and postoperative pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Propofol infusion syndrome in critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Sedation assessment in critically ill adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Delirium in the intensive care unit.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Six-month neuropsychological outcome of medical intensive care unit patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Intensive care unit syndrome/delirium is associated with anemia, drug therapy and duration of ventilation treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

The impact of delirium on the survival of mechanically ventilated patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Management of the agitated intensive care unit patient

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Delirium in an intensive care unit: a study of risk factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Comparative sensitivity of a simulated driving task to self-report, physiological, and other performance measures during prolonged wakefulness.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Dexmedetomidine and cardiac arrest

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050508

31 March 2020

Identifiers

DOI

10.2146/AJHP050508

1 reference

15 August 2017

1 reference